BS

Bespoke Extracts IncOOTC BSPK Stock Report

Last reporting period 30 Sep, 2024

Updated 18 Dec, 2024

Last price

Market cap $B

0.001

Micro

Exchange

OOTC - OTC

BSPK Stock Analysis

BS

Uncovered

Bespoke Extracts Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-44/100

Low score

Market cap $B

0.001

Dividend yield

Shares outstanding

10.002 B

Website

Bespoke Extracts, Inc. engages in the production of a proprietary line of natural cannabidiol products in the form of tinctures and capsules for the nutraceutical and veterinary markets. The company is headquartered in Denver, Colorado. The company went IPO on 2004-11-30. The firm is focused on selling its formulated, quality, hemp-derived cannabidiol (CBD) products direct to consumers, through its e-commerce store. The company offers consulting services for companies associated with the cannabis and hemp industries in various stages of development. The firm offers a range of products, such as Manuka Honey Infused CBD Cream, Manuka Honey Infused CBD Tincture, Manuka Bundle Tinctures + Cream, Bespoke 3C, Bespoke Comfort, Bespoke Recovery, Bespoke Active and Bespoke Serenity Capsules. Its product is available in various color, including berry, citrus and mint.

View Section: Eyestock Rating